Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. (BIO-B) Stock Overview
Explore Bio-Rad Laboratories, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
7.2B
P/E Ratio
9.35
EPS (TTM)
$27.84
ROE
0.11%
BIO-B Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Bio-Rad Laboratories, Inc. (BIO-B) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 33.77, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $88.35.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 9.35 and a market capitalization of 7.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.